) --

Biosante Pharmaceuticals

TST Recommends



) is trading at unusually high volume Tuesday with 21 million shares changing hands. It is currently at 4.2 times its average daily volume and trading down 10 cents (-9.5%) at 95 cents as of 10:40 a.m. ET.

Biosante has a market cap of $72.2 million and is part of the

health care

sector and


industry. Shares are up 109.1% year to date as of the close of trading on Monday.

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, develops products for female sexual health and oncology.

TheStreet Ratings rates Biosante as a


. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow and generally disappointing historical performance in the stock itself. You can view the full

Biosante Ratings Report


See all heavy volume stocks in our

stocks moving on unusual volume list

or get investment ideas from our

investment research center


Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options